SCHEMBL4221979

SCHEMBL4221979

NC(=O)c1ccsc1-c1cccnc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 4/20 0.57
CYP3A4 P08684 3/20 0.57
CYP2C19 P33261 2/20 0.57
CYP2E1 P05181 2/20 0.57
CYP2C9 P11712 2/20 0.57
CYP2B6 P20813 2/20 0.57
CYP2D6 P10635 1/20 0.57
MKNK1 Q9BUB5 10/20 0.54
MKNK2 Q9HBH9 9/20 0.54
MAPK8 P45983 1/20 0.52
F7 P08709 1/20 0.47
F3 P13726 1/20 0.47
SARM1 Q6SZW1 1/20 0.47
SIRT2 Q8IXJ6 1/20 0.47
SIRT6 Q8N6T7 1/20 0.47
SIRT1 Q96EB6 1/20 0.47
SIRT3 Q9NTG7 1/20 0.47
SIRT5 Q9NXA8 1/20 0.47
SIRT4 Q9Y6E7 1/20 0.47
PKN1 Q16512 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6623848 0.79 BCAT2 (0.55) MAPK8LMNAKMT2A
SCHEMBL24318549 0.78 CYP2A6 (0.66) CYP2A6CYP3A4CYP2C19CYP2E1CYP2C9
SCHEMBL6669302 0.77 BCAT2 (0.68) CYP2A6CYP3A4CYP2C19CYP2E1CYP2C9
SCHEMBL28019336 0.75 MKNK1 (0.58) CYP2A6CYP3A4MKNK1MKNK2F7
SCHEMBL30514275 0.75 BCAT2 (0.67) CYP2A6MKNK1MKNK2F7F3
SCHEMBL167082 0.75 BCAT2 (0.67) CYP2A6MKNK1MKNK2F7F3
SCHEMBL27880990 0.75 MKNK1 (0.58) CYP2A6CYP3A4MKNK1MKNK2F7
SCHEMBL31227976 0.75 BCAT2 (0.67) CYP2A6MKNK1MKNK2F7F3
Hydrochloric Acid SCHEMBL30165666 0.73 BCAT2 (0.65) CYP2A6MKNK1MKNK2F7F3
Hydrochloric Acid SCHEMBL27890957 0.73 BCAT2 (0.65) CYP2A6MKNK1MKNK2F7F3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054396-A1 SUBSTITUTED THIOPHENES AND USES THEREOF ASTRAZENECA AB (SE) 2009-02-26 US disclosed
US-7423061-B2 Substitute thiophenes and uses thereof ASTRAZENECA AB (SE) 2008-09-09 US disclosed
US-20060281666-A1 Substitute thiophenes and uses therof ASTRAZENECA AB (SE) 2006-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054396-A1 SUBSTITUTED THIOPHENES AND USES THEREOF TPMT, ABCG2, TYMP CYP2A6 143/4885CYP3A4 57/4885CYP2C19 62/4885
US-20060281666-A1 Substitute thiophenes and uses therof TYMP, TPMT, MGMT CYP2A6 747/4885CYP3A4 808/4885CYP2C19 637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.